Western States Biopharmaceuticals and University of Colorado Announce Exclusive Licensing Agreement for TCISM™ Targets to Treat Autoimmune Diseases

Thursday, July 8, 2010 General News
Email Print This Page Comment bookmark
Font : A-A+

Licensed Technology is a Novel Approach to Treating Inflammatory Disease while Preserving Immune Protection

For Western States Biopharmaceuticals:

Felicia Vonella, LAS Communications

(917) 826-3427

[email protected]ommunications.com

For University of Colorado:

Lindsay Polak

Technology Transfer Office

(303) 735-5518

[email protected]



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook